Q4 2025 13F Holders as of 31 Dec 2025
-
Type / Class
-
Equity / Common Stock, $0.007 par value
-
Shares outstanding
-
2,027,012
-
Total 13F shares
-
78,422
-
Share change
-
-198,434
-
Total reported value
-
$92,539
-
Price per share
-
$1.18
-
Number of holders
-
9
-
Value change
-
-$717,896
-
Number of buys
-
6
-
Number of sells
-
8
Institutional Holders of bioAffinity Technologies, Inc. - Common Stock, $0.007 par value (BIAF) as of Q4 2025
As of 31 Dec 2025,
bioAffinity Technologies, Inc. - Common Stock, $0.007 par value (BIAF) was held by
9 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
78,422 shares.
The largest 9 holders included
GEODE CAPITAL MANAGEMENT, LLC, NORTHERN TRUST CORP, CITADEL ADVISORS LLC, TWO SIGMA SECURITIES, LLC, CITIGROUP INC, Tower Research Capital LLC (TRC), IFP Advisors, Inc, BANK OF AMERICA CORP /DE/, and MORGAN STANLEY.
This page lists
9
institutional shareholders reporting positions in this security
for the Q4 2025 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.